EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,570.00
-10.00 (-0.15%)
Jun 10, 2026, 3:30 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 217.35 billion as of June 10, 2026. Its market cap has increased by 18.59% in one year.
Market Cap
217.35B
Enterprise Value
339.85B
Revenue
490.70B
Ranking
n/a
PE Ratio
6.51
Stock Price
6,570.00
Market Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 217.35B, an increase of 525.32%. That is a compound annual growth rate of 35.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 217.35B | 13.08% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genomictree | 272.43B |
| Anterogen.Co.,Ltd. | 264.16B |
| NeoImmuneTech | 247.66B |
| BINEX | 238.86B |
| GC Cell | 236.08B |
| HLB Therapeutics | 228.17B |
| Helixmith | 212.28B |
| Bioneer | 188.42B |